Clinical application and analysis of hepatitis C virus NS3 antigen detection by ELISA in human serum

Chinese Medical Journal

Volumn 120, Issue 4, 2007, Pages 294-299

  Xie, Li ^a,b   Wu, Xiao Dong ^b   Huang, De Zhuang ^a   Chen, Hai Lun ^c   He, Li Xiang ^a   Wang, Jian ^a   Han, Da Kang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Anti HCV; ELISA; Hepatitis C virus; Hepatitis C virus NS3 antigen; Hepatitis C virus RNA

Indexed keywords

HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; HEPATITIS C NS3 ANTIGEN; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; ECONOMIC ASPECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; SERUM; VALIDATION PROCESS; VIRUS NEUTRALIZATION;

EID: 33947181913     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200702020-00008     Document Type: Article

References (41)

1. Xing WG, Zheng HJ. Laboratory test for hepatitis C should be more reliable. Chin J Hepato (Chin) 2004; 12: 170-171.
2. Levine CD, Ghalib RH. Assessment of the patient who failed treatment for chronic hepatitis C. Gastroenterol Nurs 2005; 28(S3): S24-S30.
3. Zhuang H. Pay attention to the first version of "Guidelines on Hepatitis C" in China. Chin J Hepato (Chin) 2004; 12: 193.
4. Re V, Gallego S, Trevino E, Barbas G, Dominguez C, Elbarcha O, et al. Evaluation of five screening tests licensed in Argentina for detection of hepatitis C virus antibodies. Mem Inst Oswaldo Cruz 2005; 100: 303-307.
5. Gallarda JL, Dragon E. Blood screening by nucleic acid amplification technology: current issues, future challenge. Mol Diagn 2000; 5: 11-22.
6. Fabrizi F, Lunghi G, Aucella F, Mangano S, Barbisoni F, Bisegna S, et al. Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients. J Clin Microbiol 2005; 43: 414-420.
7. Saldanha J. Validation and standardization of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products. J Clin Virol 2001; 20: 7-13.
8. Tobler LH, Stramer SL, Lee SR, Baggett D, Wright D, Hirschkorn D, et al. Performance of ORTHO HCV core antigen and trak-C assays for detection of viraemia in pre-seroconversion plasma and whole blood donors. Vox Sang 2005; 89: 201-207.
9. Xie L, Huang DZ, Shi HB, He LX, Jin HY. The detection of Hepatitis C virus NS3 antigen in human serum by sandwich enzyme-linked immunoassay. Chin J Lab Med (Chin) 2005; 28: 1159-1162.
10. Xie L, Chen WR, Zhang MC, Huang DZ, He LX. Establishment and Identification of Monoclonal Antibody of Hepatitis C Virus. Tianjin Med J (Chin) 2005; 33: 492-494.
11. Society of Infectious Diseases and Society of Hepatology, Chinese Medical Association. Preventive and therapeutical scheme of virus Hepatitis. Chin J Hepato (Chin) 2000; 8: 324-329.
12. Tanaka E, Ohue C, Aoyagi K, Yamaguchi K, Yagi S, Kiyosawa K, et al. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology 2000; 32: 388-393.
13. Peterson J, Green G, Iida K, Caldwell B, Kerrison P, Bernich S, et al. Detection of hepatitis C core antigen in the antibody negative "window" phase of hepatitis C infection. Vox Sang 2000; 78: 80-85.
14. Widell A, Molnegren V, Pieksma F, Calmann M, Peterson J, Lee SR. Detection of hepatitis C core antigen in serum or plasma as a marker of hepatitis C viraemia in the serological window-phase. Transfusion Med 2002; 12: 107-113.
15. Wang LB, Zhao JF. The infection and significance of anti-HCV negative blood donors. J Bengbu Med Coll 2000; 25: 442.
16. Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology 2002; 36: S65-S73.
17. Xess A, Kumar M, Minz S, Sharma HP, Shahi SK. Prevalence of hepatitis B and hepatitis C virus coinfection in chronic liver disease. Indian J Pathol Microbiol 2001; 44: 253-255.
18. Bukhtiari N, Hussain T, Iqbal M, Malik AM, Qureshi AH, Hussain A. Hepatitis B and C single and co-infection in chronic liver disease and their effect on the disease pattern. J Pak Med Assoc 2003; 53: 136-140.
19. Kazemi-Shirazi L, Petermann D, Muller C. Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C. J Hepatol 2000; 33: 785-790.
20. Soderholm J, Ahlen G, Kaul A, Frelin L, Alheim M, Barnfield C, et al. Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut 2006; 55: 266-274.
21. Veillon P, Payan C, Picchio G, Maniez-Montreuil M, Guntz P, Lunel F. Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy. J Clin Microbiol. 2003; 41:3212-3220.
22. Zhuang H. Towards research on hepatitis C. Chin J Hepato (Chin) 2004; 12: 65-66.
23. Tanaka Y, Takagi K, Fujihara T, Kitsugi K, Fujiwara K, Hiramatsu K, et al. High stability of enzyme immunoassay for hepatitis C virus core antigen evaluation before and after incubation at room temperature. Hepatol Res 2003; 26: 261-267.
24. Zanetti AR, Romano L, Brunetto M, Colombo M, Bellati G, Tackney C. Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy. J Med Virol 2003; 70: 27-30.
25. Maynard M, Pradat P, Berthillon P, Picchio G, Voirin N, Martinot M, et al. Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy. J Viral Hepat 2003; 10: 318-323.
26. Enomoto M, Nishiguchi S, Tamori A, Kohmoto M, Habu D, Sakaguchi H, et al. Chemiluminescence enzyme immunoassay for monitoring hepatitis C virus core protein during interferon-alpha2b and ribavirin therapy in patients with genotype 1 and high viral loads. J Med Virol 2005; 77: 77-82.
27. Iijima, A, Tanaka E, Kobayashi M, Yagi S, Mizokami M, Kiyosawa K. Relationship between histological prognosis of chronic hepatitis C and amount of hepatitis C virus core protein in serum. J Gastroenterol Hepatol 2000; 15: 311-319.
28. Tanaka E, Kiyosawa K, Matsumoto A, Kashiwakuma T, Hasegawa A, Mori H, et al. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon α. Hepatology 1996; 23: 1330-1333.
29. Mario UM, Antonella C, Piet B. Significance of the immune response to a major, conformation B-cell epitope on the hepatitis C virus NS3 region defined by a human monocloned antibody. J Virol 1994; 68: 4829-4836.
30. Huang JS, Ren DM. The structure and function of HCV Genome. In: Huang JS, RenDM, eds. Hepatitis C. Beijing: People's Military Medical Press; 2000: 56-70.
31. Neville JA, Prescott LE, Bhattacherjee V, Adams N, Pike I, Rodgers B, et al. Antigenic variation of core, NS3 and NS5 proteins among genotypes of hepatitis C virus. J Clin Microbiol 1997; 35: 3062-3070.
32. Sun Y, Xia YW, Gao SL, Yang YY. The correlation and clinical significance of HCV-NS3 antigen in liver tissue and different modes in serum of HCV infection. J Prac Med 1997; 13: 141.
33. Ishido S, Fujita T, Hotta H. Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus. Biochem Biophys Res Commun 1998; 244: 35-40.
34. Tai CL, Chi WK, Chen DS, Hwang LH. The helicase activity associated with hepatitis C virus nonstructural protein 3(NS3). J Virol 1996; 70: 8477-8484.
35. Laperche S, Elghouzzi MH, Morel P, Asso-Bonnet M, Le Marrec N, Girault A, et al. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing? Transfusion 2005; 45: 1965-1972.
36. Lin CS, Gao ZL. The detection of Hapatits C core antigen with enzyme linking immunosorbent assay. Fore Med Sci (Inte Med Sect) 2002; 29: 523-532.
37. Ansaldi F, Bruzzone B, Testino G, Bassetti M, Gasparini R, Crovari P, et al. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection. J Viral Hepat 2006; 13: 5-10.
38. Icardi G, Ansaldi F, Bruzzone BM, Durando P, Lee S, de Luigi C, et al. Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen. J Clin Microbio 2001; 39: 3110-3114.
39. Lagging LM, Garcia CE, Westin J, Wejstal R, Norkrans G, Dhillon AP, et al. Comparison of serum hepatits C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time. J Clin Microbiol 2002; 40: 4224-4229.
40. Lee DH and Prince AM. Automation of nucleic acid extraction for NAT screening of individual blood units. Transfusion 2001; 41: 483-487.
41. Yang DL. Diagnostic tests for hepatitis C. Chin J Hepato (Chin) 2004; 2: 104.